Related references
Note: Only part of the references are listed.Computer-assisted mitotic count using a deep learning-based algorithm improves interobserver reproducibility and accuracy
Christof A. Bertram et al.
VETERINARY PATHOLOGY (2022)
Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
P. G. Casali et al.
ANNALS OF ONCOLOGY (2022)
Deep Convolutional Neural Networks Detect Tumor Genotype from Pathological Tissue Images in Gastrointestinal Stromal Tumors
Cher-Wei Liang et al.
CANCERS (2021)
Deep learning in histopathology: the path to the clinic
Jeroen van der Laak et al.
NATURE MEDICINE (2021)
Accuracy and efficiency of an artificial intelligence tool when counting breast mitoses
Liron Pantanowitz et al.
DIAGNOSTIC PATHOLOGY (2020)
A deep learning model to predict RNA-Seq expression of tumours from whole slide images
Benoit Schmauch et al.
NATURE COMMUNICATIONS (2020)
Pan-cancer computational histopathology reveals mutations, tumor composition and prognosis
Yu Fu et al.
NATURE CANCER (2020)
Evaluating reproducibility of AI algorithms in digital pathology with DAPPER
Andrea Bizzego et al.
PLOS COMPUTATIONAL BIOLOGY (2019)
Predicting breast tumor proliferation from whole-slide images: The TUPAC16 challenge
Mitko Veta et al.
MEDICAL IMAGE ANALYSIS (2019)
Deep learning assisted mitotic counting for breast cancer
Maschenka C. A. Balkenhol et al.
LABORATORY INVESTIGATION (2019)
Deep learning-based classification of mesothelioma improves prediction of patient outcome
Pierre Courtiol et al.
NATURE MEDICINE (2019)
Design Characteristics of Studies Reporting the Performance of Artificial Intelligence Algorithms for Diagnostic Analysis of Medical Images: Results from Recently Published Papers
Dong Wook Kim et al.
KOREAN JOURNAL OF RADIOLOGY (2019)
Adjuvant therapy with imatinib in gastrointestinal stromal tumors (GISTs)-review and perspectives
Marie Laurent et al.
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning
Nicolas Coudray et al.
NATURE MEDICINE (2018)
Improved sarcoma management in a national network of reference centers: Analysis of the NetSarc network on 13,454 patients treated between 2010 and 2014.
Jean-Yves Blay et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Interobserver Variability of Mitotic Index and Utility of PHH3 for Risk Stratification in Gastrointestinal Stromal Tumors
Ahmad Alkhasawneh et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2015)
Computationally efficient confidence intervals for cross-validated area under the ROC curve estimates
Erin LeDell et al.
ELECTRONIC JOURNAL OF STATISTICS (2015)
Tumor Genotype Is an Independent Prognostic Factor in Primary Gastrointestinal Stromal Tumors of Gastric Origin: A European Multicenter Analysis Based on ConticaGIST
Agnieszka Wozniak et al.
CLINICAL CANCER RESEARCH (2014)
Prognostic value of mutational characteristics in gastrointestinal stromal tumors: a single-center experience in 275 cases
Ming Wang et al.
MEDICAL ONCOLOGY (2014)
Outcome of Patients with Platelet-Derived Growth Factor Receptor Alpha-Mutated Gastrointestinal Stromal Tumors in the Tyrosine Kinase Inhibitor Era
Philippe A. Cassier et al.
CLINICAL CANCER RESEARCH (2012)
Gastrointestinal stromal tumours: origin and molecular oncology
Christopher L. Corless et al.
NATURE REVIEWS CANCER (2011)
Gastrointestinal stromal tumors: Pathology and prognosis at different sites
Markku Miettinen et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2006)
KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours
Maria Debiec-Rychter et al.
EUROPEAN JOURNAL OF CANCER (2006)
An update on molecular genetics of gastrointestinal stromal tumours
L. Tornillo et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
Gastrointestinal stromal tumors:: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era -: A population-based study in western Sweden
B Nilsson et al.
CANCER (2005)
Deletion of Trp-557 and Lys-558 in the juxtamembrane domain of the c-kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors
E Wardelmann et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
GD Demetri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant
E Wardelmann et al.
MODERN PATHOLOGY (2002)
Safety and efficacy of imatinib (ST1571) in metastatic gastrointestinal stromal tumours: a phase I study
AT van Oosterom et al.
LANCET (2001)
Share Paper
